Viewing data from:

TRIENTINE HYDROCHLORIDE

ANDA

TRIENTINE HYDROCHLORIDE | A216356 | HETERO LABS LTD UNIT III

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: SYPRINE(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 1 NDC

Highest NADAC/Unit

$2.30

per ea

Lowest NADAC/Unit

$2.30

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
31722068301TRIENTINE HCL 250 MG CAPSULE	$2.30	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain9 active DMFs2 inactive

9 active API suppliers hold Drug Master Files for this ingredient.

CHEMWERTH INCTRIENTINE HYDROCHLORIDE USP

DMF 290192015

TAPI NL BVTRIENTINE HYDROCHLORIDE USP

DMF 290852015

BIOPHORE INDIA PHARMACEUTICALS PVT LTDTRIENTINE HYDROCHLORIDE

DMF 295272015

SS PHARMA LLCTRIENTINE HYDROCHLORIDE USP

DMF 308782016

NAVINTA LLCTRIENTINE HYDROCHLORIDE USP

DMF 309052016

MSN ORGANICS PRIVATE LTDTRIENTINE HYDROCHLORIDE USP

DMF 310852016

EMCURE PHARMACEUTICALS LTDTRIENTINE HYDROCHLORIDE USP

DMF 313952017

COHANCE LIFESCIENCES LTDTRIENTINE HYDROCHLORIDE

DMF 329562018

DASAMI LAB PRIVATE LTDTRIENTINE HYDROCHLORIDE

DMF 349102020

TIANISH LABORATORIES PRIVATE LTDInactiveTRIENTINE HYDROCHLORIDE USP

DMF 321132017

BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO LTDInactiveTRIENTINE HYDROCHLORIDE USP

DMF 377772022

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 250MG

0 patents0 exclusivities▴

CAPSULE;ORAL | Approved: Jun 23, 2022

No patent or exclusivity listings for this strength.